Cramer’s Six Steps to Analyze a Spec Stock

[cnbc 3000077634]

Mad Money’s Cramer takes a look at speculative stock, Solazyme, but cautions investors to follow the six steps to analyze the stock first, and then if you can stomach the risk, use only limit orders to buy.

With a reach of over 400 million CNBC is ground zero for traders and investors monitoring the financial world.

Video © and provided by CNBC.

Be the first to comment

Leave a Reply